CEWG Steering Committee
M. William Audeh, MD, MS
(2021-2024)Chief Medical Officer
Agendia, Inc.
Irvine, California
Medical Staff Member
Cedars-Sinai Medical Center
Los Angeles, California
Alberto Bardelli, PhD
(2021-2024)Full Professor, Department of Oncology
University of Torino
Director, Laboratory of Molecular Oncology
Candiolo Cancer Institute
Candiolo, Italy
Michael C. Campbell, PhD
(2021-2024)Assistant Professor, Department of Biology
Howard University
Washington, D.C.
Peter J. Campbell, MBChB, PhD
(2021-2024)Head of Cancer, Ageing and Somatic Mutation
Senior Group Leader
Wellcome Trust Sanger Institute
Hinxton, Cambridgeshire, United Kingdom
Christina Curtis, PhD, MSc
(2021-2024)Professor of Medicine and Genetics
Stanford University School of Medicine
Director, Breast Cancer Translational Research
Co-director, Molecular Tumor Board
Stanford Cancer Institute
Stanford, California
James V. DeGregori, PhD
(2021-2024)Professor, Department of Biochemistry and Molecular Genetics
University of Colorado School of Medicine
Aurora, Colorado
Robert A. Gatenby, MD
(2021-2024)Chair, Department of Radiology
Co-director, Cancer Biology and Evolution Program
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida
Marco Gerlinger, MD
(2021-2024)Team Leader, Translational Oncogenomics Laboratory
Centre for Evolution and Cancer
The Institute of Cancer Research
London, United Kingdom
Michael A. Gillette, MD, PhD
(2021-2024)Senior Group Leader, Proteomics and Biomarker Discovery
Broad Institute of MIT and Harvard
Cambridge, Massachusetts
Trevor Graham, PhD
(2021-2024)Professor of Cancer Evolution
Deputy Centre Lead and Group Leader
Barts Cancer Institute
London, United Kingdom
Henry H.Q. Heng, PhD
(2021-2024)Professor of Molecular Medicine, Genetics and Pathology
Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, Michigan
Giulia C. Kennedy, PhD
(2021-2024)Chief Scientific Officer and Chief Medical Officer
Veracyte, Inc.
San Francisco, Calfornia
Carlo C. Maley, PhD
(2021-2024)Director, Arizona Cancer and Evolution Center;
Associate Professor, Biodesign Institute and School of Life Sciences
Arizona State University
Tempe, Arizona
Perry S. Marshall, BS
(2021-2024)Marketing Consultant and Author
Chicago, Illinois
Andriy Marusyk, PhD
(2021-2024)Associate Professor
Department of Cancer Physiology
Moffitt Cancer Center
Tampa, Florida
Nicholas McGranahan, PhD
(2021-2024)Professor
University College London
London, England, United Kingdom
Paul S. Mischel, MD
(2021-2024)Professor and Vice Chair of Research
Department of Pathology
Stanford University School of Medicine
Stanford, California
Nicholas E. Navin, PhD
(2021-2024)Associate Professor
Departments of Bioinformatics and Genetics, Division of Basic Science Research
Director, CPRIT Single Cell Genomics Center
Co-Director, Advanced Technology Genomics Core
University of Texas MD Anderson Cancer Center
Houston, Texas
Serena Nik-Zainal, MBBCh, PhD
(2021-2024)CRUK Advanced Clinician Scientist
Honorary Consultant in Clinical Genetics
University of Cambridge
Cambridge, United Kingdom
Larry Norton, MD, FAACR
(2021-2024)Department Physician-In-Chief
Breast Cancer Program
Memorial Sloan Kettering Cancer Center
New York, New York
Elizabeth O’Day, MPhil, PhD
(2021-2024)Founder and Chief Executive Officer
Olaris Therapeutics, Inc.
Waltham, Massachusetts
Azra Raza, MD
(2021-2024)Chan Soon-Shiong Professor of Medicine
Director, Myelodysplastic Syndrome Center
Columbia University
New York, New York
Andrea Sottoriva, PhD
(2021-2024)Head of the Centre for Computational Biology
Human Technopole
Milan, Italy
Director, Centre for Evolution and Cancer
The Institute of Cancer Research
London, United Kingdom
Jonathan Weissman, PhD
(2021-2024)Landon T. Clay Professor of Biology
Member, Whitehead Institute
Investigator
Howard Hughes Medical Institute
Cambridge, Massachusetts
Danny R. Welch, PhD
(2021-2024)Professor of Cancer Biology
University of Kansas Cancer Center
Kansas City, Kansas